Tag: pharmaceuticals
-
Immunotherapy Biotech Gains $325M in Venture Funds
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round.
-
Stem Cell Start-Up Raises $250M in Venture Funds
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing.
-
Trial Testing Paramedic-Delivered Stroke Drug
A clinical trial is getting underway testing a treatment for stroke delivered to patients by emergency medical technicians on the way to the hospital.
-
Artificial DNA Designed to Control Drug Delivery
Researchers in Germany are developing techniques with artificial DNA and hydrogel designed to control the sequence of drugs delivered into the body.
-
Two Biotechs Each Issue $300M+ IPOs
Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions.
-
Company Launches Attacking Cancer Proteins, Lands $67M
A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies.
-
Gut Microbe Linked to Longer Exercise Endurance
An analysis of gut microbes from elite athletes identified a particular bacterial strain, which in tests with lab mice boosted their exercise endurance.
-
CBD Shown Effective Against Staph, Strep Bacteria
Tests of synthetic cannabidiol, or CBD, show the compound is as effective as current antibiotics against a class of microbes that includes Staphyloccocus and Streptococcus bacteria.
-
Infographic – Where Vaccine Distrust is Greatest
While much attention is focused on the current measles outbreak, distrust of vaccines apparently goes beyond this one disease.
-
Energy-Efficient Process Devised for Nano-Emulsions
A more efficient process using less energy is being developed for producing emulsions with tiny droplets to deliver drugs or cosmetics through the skin.